# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stifel analyst Mathew Blackman initiates coverage on Penumbra (NYSE:PEN) with a Buy rating and announces Price Target of $238.
Penumbra, Inc. (NYSE:PEN), the world's leading thrombectomy company, announced it has secured CE Mark in Europe for the la...
Leerink Partners analyst Mike Kratky initiates coverage on Penumbra (NYSE:PEN) with a Outperform rating and announces Price ...
BTIG analyst Ryan Zimmerman maintains Penumbra (NYSE:PEN) with a Buy and raises the price target from $187 to $224.
Citigroup analyst Joanne Wuensch maintains Penumbra (NYSE:PEN) with a Neutral and raises the price target from $178 to $200.